Austin Davis Biologics Ltd 06878611 false 2022-05-01 2023-04-30 2023-04-30 The principal activity of the company is equine science and technology services. Digita Accounts Production Advanced 6.30.9574.0 true 06878611 2022-05-01 2023-04-30 06878611 2023-04-30 06878611 core:CurrentFinancialInstruments core:WithinOneYear 2023-04-30 06878611 bus:Micro-entities 2022-05-01 2023-04-30 06878611 bus:AuditExemptWithAccountantsReport 2022-05-01 2023-04-30 06878611 bus:FullAccounts 2022-05-01 2023-04-30 06878611 bus:SmallCompaniesRegimeForAccounts 2022-05-01 2023-04-30 06878611 bus:RegisteredOffice 2022-05-01 2023-04-30 06878611 bus:Director1 2022-05-01 2023-04-30 06878611 bus:Director2 2022-05-01 2023-04-30 06878611 bus:Director3 2022-05-01 2023-04-30 06878611 bus:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30 06878611 countries:EnglandWales 2022-05-01 2023-04-30 06878611 2021-05-01 2022-04-30 06878611 2022-04-30 06878611 core:CurrentFinancialInstruments core:WithinOneYear 2022-04-30 iso4217:GBP xbrli:pure

Registration number: 06878611

Austin Davis Biologics Ltd

Unaudited Filleted Financial Statements

for the Year Ended 30 April 2023

 

Austin Davis Biologics Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Austin Davis Biologics Ltd

Company Information

Directors

Dr C Austin

Mr A J Austin

Professor P J Davis

Registered office

Unit 1
Denfield Lodge
Lower Street
Great Addington
Northamptonshire
NN14 4BL

Accountants

Levett & Associates Ltd
Chartered Certified Accountants
2nd Floor
46-46a High Street
Olney
Buckinghamshire
MK46 4BE

 

Austin Davis Biologics Ltd

(Registration number: 06878611)
Balance Sheet as at 30 April 2023

2023
£

2022
£

Fixed assets

201,670

91,214

Current assets

608,996

492,602

Creditors: Amounts falling due within one year

(91,653)

(64,850)

Net current assets

517,343

427,752

 

719,013

518,966

Capital and reserves

719,013

518,966

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 1
Denfield Lodge
Lower Street
Great Addington
Northamptonshire
NN14 4BL

These financial statements were authorised for issue by the Board on 25 September 2023.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 10 (2022 - 7).

For the financial year ending 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 25 September 2023 and signed on its behalf by:
 

 

Austin Davis Biologics Ltd

(Registration number: 06878611)
Balance Sheet as at 30 April 2023

.........................................
Dr C Austin
Director